نتایج جستجو برای: dexrazoxane

تعداد نتایج: 227  

Journal: :Acta pharmaceutica 2013
Tiam Feridooni Chris Mac Donald Di Shao Pollen Yeung Remigius U Agu

To investigate potential prevention or attenuation of anti- cancer drug induced cardiotoxicity using anti-ischemic drugs, a rat myoblast (H9c2) cell line was used as our in vitro cardiac model. Irinotecan and doxorubicin were found to be cytotoxic for the H9c2 cell line with IC50 of 30.69 ± 6.20 and 20.94 ± 6.05 mmol L-1, respectively. 5-Flurouracil and cladribine were not cytotoxic and thus IC...

Journal: :The oncologist 2008
Robert C Kane W David McGuinn Ramzi Dagher Robert Justice Richard Pazdur

Management of anthracycline extravasation is problematic and most reports are anecdotal. On September 6, 2007, the U.S. Food and Drug Administration approved Totect 500 mg (dexrazoxane hydrochloride for injection) for the treatment of extravasation resulting from i.v. anthracycline chemotherapy. In two studies, a total of 57 evaluable patients experienced extravasation from peripheral vein or c...

Journal: :The European respiratory journal 2008
C Riganti S Doublier E Aldieri S Orecchia P G Betta E Gazzano D Ghigo A Bosia

Human malignant mesothelioma (HMM), which is strongly related to asbestos exposure, exhibits high resistance to many anticancer drugs. Asbestos fibre deposition in the lung may cause hypoxia and iron chelation at the fibre surface. Hypoxia-inducible factor (HIF)-1alpha, which is upregulated by a decreased availability of oxygen and iron, controls the expression of membrane transporters, such as...

2016
Sabry M. Attia Sheikh F. Ahmad Mushtaq A. Ansari Ahmed Nadeem Othman A. Al-Shabanah Mohammed M. Al-Harbi Saleh A. Bakheet

[This corrects the article DOI: 10.1371/journal.pone.0163703.].

Journal: :Journal of the American College of Cardiology 2002

2016
Rachael Chang Nick Murray

Anthracycline extravasation is a feared complication of intravenous (i.v.) chemotherapy due to the tissue toxicity of this group of drugs. We describe a 54-year-old woman with history of stage IIIa breast cancer, receiving adjuvant chemotherapy consisting of doxorubicin and cyclophosphamide. The chemotherapy was administered through a Poweport® device, the position of which was confirmed with f...

Journal: :Journal of Clinical Biochemistry and Nutrition 2010

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید